Antimicrobial Silver Multilayer Coating for Prevention of Bacterial Colonization of Orthopedic Implants
- PMID: 32245004
- PMCID: PMC7143109
- DOI: 10.3390/ma13061415
Antimicrobial Silver Multilayer Coating for Prevention of Bacterial Colonization of Orthopedic Implants
Abstract
Due to increasing rates of periprosthetic joint infections (PJI), new approaches are needed to minimize the infection risk. The first goal of this study was to modify a well-established infection model to test surface-active antimicrobial systems. The second goal was to evaluate the antimicrobial activity of a silver multilayer (SML) coating. In vitro tests with SML items showed a >4 Log reduction in a proliferation assay and a 2.2 Log reduction in an agar immersion test (7 d). In the in vivo model blank and SML coated K-wires were seeded with ~2 × 104 CFU of a methicillin-sensitive Staphylococcus epidermidis (MSSE) and inserted into the intramedullary tibial canal of rabbits. After 7 days, the animals were sacrificed and a clinical, microbiological and histological analysis was performed. Microbiology showed a 1.6 Log pathogen reduction on the surface of SML items (p = 0.022) and in loosely attached tissue (p = 0.012). In the SML group 7 of 12 SML items were completely free of pathogens (cure rate = 58%, p = 0.002), while only 1 of 12 blank items were free of pathogens (cure rate = 8%, p = 0.110). No silver was detected in the blood or urine of the SML treated animals and only scarcely in the liver or adjacent lymph nodes. In summary, an in vivo infection model to test implants with bacterial pre-incubation was established and the antimicrobial activity of the SML coating was successfully proven.
Keywords: Staphylococcus epidermidis; in vivo osteomyelitis model; infection prophylaxis; periprosthetic joint infections.
Conflict of interest statement
Three of the authors (M.F., D.S., K.S.) are employees of Aesculap AG Tuttlingen, a manufacturer of orthopedic implants. One author (A.A.A.-M.) is employee of Bio-Gate AG Nuremberg, a manufacturer of antimicrobial materials. Four authors (C.F., H.J., M.Z., T.L.) are employees of the respective labs (C.F., H.J., FreyTox Gmbh Herzberg; M.Z., QualityLabs Nuremberg; T.L. TPL Path Labs Freiburg). Two of the authors (J.J.A., V.A.) are scientific advisors in Aesculap R&D projects. V.A. is member of the Supervisory Board of Bio-Gate AG (Nuremberg, Germany).
Figures











References
-
- National Joint Registry for England, Wales, Northern Ireland and the Isle of Man . 15th Annual Report 2018. National Joint Registry for England; London, UK: 2018.
-
- Australian Orthopaedic Association . Australian Orthopaedic Association National Joint Replacement Registry: Annual Report 2019. Australian Orthopaedic Association; Adelaide, Australia: 2019.
-
- Trauma Register D.G.U. Jahresbericht 2019. Endoprothesenregister Deutschland (EPRD); Berlin, Germany: 2019.
-
- Kärrholm J., Garellick G., Rogmark C., Herberts P. Swedish Hip Arthroplasty Register: Annual Report 2017. Sahlgrenska University Hospital; Gothenburg, Sweden: 2018.
LinkOut - more resources
Full Text Sources